STOCK TITAN

Haoxi Health Technology Limited - $HAO STOCK NEWS

Welcome to our dedicated page for Haoxi Health Technology news (Ticker: $HAO), a resource for investors and traders seeking the latest updates and insights on Haoxi Health Technology stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Haoxi Health Technology's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Haoxi Health Technology's position in the market.

Rhea-AI Summary

Haoxi Health Technology announced a Rebate Agreement with Jinan Yanling Biotechnology Co., for comprehensive advertising and promotion services in the health-related industries. The agreement includes a targeted advertising spend of at least RMB50 million on ByteDance's platforms. This partnership aims to enhance brand exposure, image, and market reach for Yanling and its affiliates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.13%
Tags
none
-
Rhea-AI Summary

Haoxi Health Technology entered into a Framework Contract for Cooperation on Information Placement on Media Platforms with Yiya Dental, a regional dentistry chain in China. The partnership aims to provide comprehensive advertising services on popular social media platforms, with a total cooperation fee of no less than RMB40 million ($5.5 million).

HAO's CEO highlighted the importance of social media advertising for real-time monitoring and optimization of advertising effectiveness. The collaboration is expected to enhance Yiya Dental's services and improve the overall patient experience, while HAO seeks to explore innovative advertising distribution strategies for sustainable business growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.92%
Tags
none
-
Rhea-AI Summary
Haoxi Health Technology Limited (HAO) has closed its initial public offering, raising $9,600,000 from the sale of 2,400,000 Class A ordinary shares at an IPO price of $4.00 per share. The Company's shares began trading on Nasdaq under the ticker symbol 'HAO' on January 26, 2024. The underwriters have an option to purchase an additional 360,000 shares. The proceeds will be used for working capital, acquiring or investing in technologies, solutions, or businesses, and hiring experienced employees. The registration statement was filed with the SEC on August 25, 2023, and declared effective on January 25, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Haoxi Health Technology Limited (HAO) has announced the pricing of its initial public offering of 2,400,000 Class A ordinary shares at a public offering price of $4.00 per share, resulting in gross proceeds of $9,600,000. The Company has been approved for listing on the Nasdaq Capital Market under the ticker symbol 'HAO' and is expected to commence trading on January 26, 2024. The Offering is being conducted on a firm commitment basis, with an option granted to the underwriter to purchase additional shares to cover the over-allotment option.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Haoxi Health Technology Limited

Nasdaq:HAO

HAO Rankings

HAO Stock Data

248.25M
14.61M
United States of America